BARCLAYS PLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 30 filers reported holding HARPOON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$23
+360.0%
33,791
+399.7%
0.00%
Q1 2023$5
+25.0%
6,762
+9.7%
0.00%
Q4 2022$4
-100.0%
6,162
-57.3%
0.00%
Q3 2022$14,000
-50.0%
14,4260.0%0.00%
Q2 2022$28,000
-68.2%
14,426
-17.4%
0.00%
Q1 2022$88,000
-84.3%
17,465
-76.5%
0.00%
Q4 2021$562,000
+128.5%
74,262
+138.3%
0.00%
Q3 2021$246,000
-50.8%
31,167
-13.7%
0.00%
Q2 2021$500,000
+39.7%
36,105
+111.3%
0.00%
Q1 2021$358,000
+29.2%
17,088
+2.2%
0.00%
Q4 2020$277,000
+9.9%
16,716
+12.8%
0.00%
Q3 2020$252,000
-34.2%
14,823
-35.8%
0.00%
Q2 2020$383,000
+133.5%
23,101
+62.6%
0.00%
Q1 2020$164,000
-8.9%
14,209
+16.3%
0.00%
Q4 2019$180,000
+102.2%
12,220
+87.2%
0.00%
Q3 2019$89,000
+78.0%
6,529
+70.7%
0.00%
Q2 2019$50,000
+614.3%
3,824
+403.2%
0.00%
Q1 2019$7,0007600.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,524,425$66,916,00029.45%
MPM BioImpact LLC 3,898,422$57,658,00020.43%
New Leaf Venture Partners, L.L.C. 2,921,405$43,208,0009.39%
Soleus Capital Management, L.P. 123,200$1,822,0001.76%
EcoR1 Capital, LLC 908,547$13,437,0001.21%
Orbimed Advisors 2,446,409$36,182,0000.52%
Artal Group S.A. 850,000$12,572,0000.49%
SPHERA FUNDS MANAGEMENT LTD. 384,031$5,680,0000.47%
Cormorant Asset Management, LP 649,994$9,613,0000.38%
Fosun International Ltd 190,483$2,817,0000.23%
View complete list of HARPOON THERAPEUTICS INC shareholders